Cargando…

Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam

BACKGROUND: Sporulation of Clostridium difficile during infection and persistence of spores within the gut could partly explain treatment failures and recurrence. However, the influence of antibiotics on sporulation is unclear. The objective of our study was to evaluate the impact of ciprofloxacin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garneau, Julian R, Valiquette, Louis, Fortier, Louis-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897887/ https://www.ncbi.nlm.nih.gov/pubmed/24422950 http://dx.doi.org/10.1186/1471-2334-14-29

Ejemplares similares

Piperacillin/tazobactam/vancomycin: Clostridium difficile colitis: case report
Publicado: (2021)

Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
por: Kundrapu, Sirisha, et al.
Publicado: (2016)

Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin–Tazobactam and Ceftolozane–Tazobactam in Tigecycline-Non-Susceptible Klebsiella pneumoniae
por: Li, Junjie, et al.
Publicado: (2020)

Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
por: Yang, Jihyun, et al.
Publicado: (2023)

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
por: Gonzales, Milagros, et al.
Publicado: (2010)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Clostridium difficile Spore-Macrophage Interactions: Spore Survival
por: Paredes-Sabja, Daniel, et al.
Publicado: (2012)

Aerial Dissemination of Clostridium difficile spores
por: Roberts, Katherine, et al.
Publicado: (2008)

Burden of Clostridium difficile Infections in Québec by Levy et al
por: Longtin, Yves, et al.
Publicado: (2016)

The Conserved Spore Coat Protein SpoVM Is Largely Dispensable in Clostridium difficile Spore Formation
por: Ribis, John W., et al.
Publicado: (2017)

DRESS syndrome induced by piperacillin-tazobactam
por: Sanchez-Gonzalez, Maria-Jose, et al.
Publicado: (2014)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018)

Fidaxomicin Inhibits Spore Production in Clostridium difficile
por: Babakhani, Farah, et al.
Publicado: (2012)

Fate of Ingested Clostridium difficile Spores in Mice
por: Howerton, Amber, et al.
Publicado: (2013)

2805. Extended-Infusion versus Intermittent-Infusion Piperacillin/tazobactam for High Minimum Inhibitory Concentration Pseudomonas aeruginosa Infections
por: Shifko, Carlee R, et al.
Publicado: (2023)

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014)

1414. Inoculum Effect of Piperacillin/Tazobactam Concentration on Emergence of Resistance in Klebsiella aerogenes
por: Custodio, Marco, et al.
Publicado: (2018)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination
por: Shen, Aimee
Publicado: (2015)

Regulation of Clostridium difficile Spore Formation by the SpoIIQ and SpoIIIA Proteins
por: Fimlaid, Kelly A., et al.
Publicado: (2015)

Enterobacter endophthalmitis: Treatment with intravitreal tazobactam- piperacillin
por: Singh, Trehan Hemant, et al.
Publicado: (2007)

Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Piperacillin–tazobactam as alternative to carbapenems for ICU patients
por: Pilmis, Benoit, et al.
Publicado: (2017)

Piperacillin/tazobactam: Eosinophilic-pneumonia: case report
Publicado: (2021)

2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
por: Rathod, Shardul, et al.
Publicado: (2019)

1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019)

Prediction Tools for Unfavourable Outcomes in Clostridium difficile Infection: A Systematic Review
por: Abou Chakra, Claire Nour, et al.
Publicado: (2012)

The Spore Differentiation Pathway in the Enteric Pathogen Clostridium difficile
por: Pereira, Fátima C., et al.
Publicado: (2013)

Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
por: Lao, Dominador, et al.
Publicado: (2012)

Structural Characterization of Clostridium sordellii Spores of Diverse Human, Animal, and Environmental Origin and Comparison to Clostridium difficile Spores
por: Rabi, Rebecca, et al.
Publicado: (2017)

525 Epidemiology and burden of recurrent Clostridium difficile infections
por: Sheitoyan-Pesant, Caroline, et al.
Publicado: (2014)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

Tazobactam and piperacillin-induced thrombocytopenia: A case report
por: CHEN, HONG, et al.
Publicado: (2016)

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
por: Kyriakou, Aikaterini, et al.
Publicado: (2019)

Meropenem/piperacillin/tazobactam: Drug resistance: case report
Publicado: (2021)

Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy
por: Workum, J D, et al.
Publicado: (2020)

Piperacillin/tazobactam/vancomycin: Cast nephropathy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4d6p101qhkpactqvqo54rakone